Integrated Advisors Network’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Integrated Advisors Network's GILD Position: Q3 2026 in Review
Integrated Advisors Network increased its Gilead Sciences (GILD) stake by 6.2% in Q3 2026, buying an estimated $20.2K and bringing the position to 2,461 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #524.
Integrated Advisors Network first reported a position in GILD in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.31M in Q1 2023. 1,208 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Integrated Advisors Network held 2,461 shares of Gilead Sciences worth $367K as of Q3 2026.
- Integrated Advisors Network bought 144 Gilead Sciences shares in Q3 2026, an estimated $20.2K.
- Gilead Sciences made up 0.02% of Integrated Advisors Network's portfolio in Q3 2026, its #524 holding.
- Integrated Advisors Network first reported a position in Gilead Sciences in Q4 2019 and has held it in 28 quarters since.
- Integrated Advisors Network's Gilead Sciences position peaked at $1.31M in Q1 2023.
- 1,208 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.